ARTICLE | Company News
Institut National de la Sante et de la Recherche Medicale, ElsaLys Biotech deal
February 22, 2016 8:00 AM UTC
The institute granted ElsaLys exclusive, worldwide rights to CD160 for use in ophthalmology. The company and institute did not respond to inquiries. Last year, MABLife S.A.S (Evry, France) granted E...